Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
AJ Grossberg, LC Chu, CR Deig… - CA: a cancer journal …, 2020 - Wiley Online Library
Despite tremendous gains in the molecular understanding of exocrine pancreatic cancer,
the prognosis for this disease remains very poor, largely because of delayed disease …
the prognosis for this disease remains very poor, largely because of delayed disease …
[HTML][HTML] Clinical trial design in the era of precision medicine
E Fountzilas, AM Tsimberidou, HH Vo, R Kurzrock - Genome medicine, 2022 - Springer
Recent rapid biotechnological breakthroughs have led to the identification of complex and
unique molecular features that drive malignancies. Precision medicine has exploited next …
unique molecular features that drive malignancies. Precision medicine has exploited next …
Management of cancer cachexia: ASCO guideline
EJ Roeland, K Bohlke, VE Baracos, E Bruera… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide evidence-based guidance on the clinical management of cancer
cachexia in adult patients with advanced cancer. METHODS A systematic review of the …
cachexia in adult patients with advanced cancer. METHODS A systematic review of the …
[HTML][HTML] The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
Highlights•This ESMO Guideline provides key recommendations on the role of PROMs
during the care of patients with cancer.•It covers the use of PROMs in patients with cancer …
during the care of patients with cancer.•It covers the use of PROMs in patients with cancer …
Epithelial ovarian cancer
Epithelial ovarian cancer generally presents at an advanced stage and is the most common
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …
[HTML][HTML] Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
Background Digital health provides solutions that capture patient-reported outcomes (PROs)
and allows symptom monitoring and patient management. Digital therapeutics is the …
and allows symptom monitoring and patient management. Digital therapeutics is the …
Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy
K Absolom, L Warrington, E Hudson… - Journal of Clinical …, 2021 - eprints.whiterose.ac.uk
PURPOSE Electronic patient self-Reporting of Adverse-events: Patient Information and
aDvice (eRAPID) is an online eHealth system for patients to self-report symptoms during …
aDvice (eRAPID) is an online eHealth system for patients to self-report symptoms during …
Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
E Basch, AM Deal, AC Dueck, HI Scher, MG Kris… - Jama, 2017 - jamanetwork.com
Methods| The study was approved by the Memorial Sloan Kettering institutional review
board and written informed consent was obtained from participants. Consecutive patients …
board and written informed consent was obtained from participants. Consecutive patients …
The increasing value of eHealth in the delivery of patient-centred cancer care
The increasing use of eHealth has ushered in a new era of patient-centred cancer care that
moves beyond the traditional in-person care model to real-time, dynamic, and technology …
moves beyond the traditional in-person care model to real-time, dynamic, and technology …
Bladder cancer
O Sanli, J Dobruch, MA Knowles, M Burger… - Nature reviews Disease …, 2017 - nature.com
Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
mortality and cost. Environmental or occupational exposures to carcinogens, especially …